A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalhes bibliográficos
Autor principal:	Noor, Fouzia
Outros Autores:	Akter, Raushanara
Formato:	Thesis
Idioma:	English
Publicado em:	Brac University 2024
Assuntos:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Acesso em linha:	http://hdl.handle.net/10361/22049

Registos relacionados

Potential of liposomes for the treatment of lung cancer- a review
Por: Mim, Shanzida
Publicado em: (2023)

A review on targeted therapies for lung cancer
Por: Ashraf, Anushey
Publicado em: (2023)

Molecules associated with the development of lung cancer
Por: Rahman, Adree, et al.
Publicado em: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Por: Rahman, Tasnim
Publicado em: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Por: Jeba, Joynob
Publicado em: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Por: Razna, Amrin Islam
Publicado em: (2019)

Immunotherapy in the Management of Lung Cancer
Por: Tasnim, Humayra
Publicado em: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Por: Pial, Sazia Afrin
Publicado em: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Por: Das, Reshita
Publicado em: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Por: Tania, Umme
Publicado em: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Por: Zangmo, Thinley
Publicado em: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Por: Hoque, Ismoth Ara
Publicado em: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Por: Shabnam, Musharrat
Publicado em: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Por: Paul, Pulock
Publicado em: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Por: Bristy, Israt Zerin
Publicado em: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Por: Khondokar, Faiza
Publicado em: (2022)

A comprehensive review on drug repurposing in cancer treatment
Por: Sarkar, Onusree
Publicado em: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
Por: Raihan, Dilraj
Publicado em: (2024)

Lung cancer detection and classification using machine learning
Por: Arefin, Mahbubul, et al.
Publicado em: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Por: Nandy, Aditi
Publicado em: (2022)

Recent advancement on breast cancer detection and treatment
Por: Rahman, Sanjida
Publicado em: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Por: Chakraborty, Anuradha
Publicado em: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Por: Jahan, Nusrat
Publicado em: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Por: Nahar, Kamrun
Publicado em: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Por: Mukti, Roushney Fatima, et al.
Publicado em: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
Por: Hasan, Samir, et al.
Publicado em: (2024)

Natural products and their combinatory effects in breast cancer treatment
Por: Siddique, Md. Ayman
Publicado em: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
Por: Islam, Ankita
Publicado em: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
Por: Hoque, Syeda Mehren
Publicado em: (2024)

Microneedles in pain management of Cancer
Por: Islam, Shafiqul
Publicado em: (2022)

Breast cancer therapy through Liposomal drug delivery system
Por: Ome, Nusrat Jahan
Publicado em: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
Por: Hossain, Safa Binte
Publicado em: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Por: Muntaha, Habibatul
Publicado em: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Karim, Samia Binte
Publicado em: (2024)

Biosimilar in lymphoma treatment
Por: Tanisha, Mehrin Haque
Publicado em: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Por: Kamal, Tasnova
Publicado em: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Por: Parvez, Safi
Publicado em: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Por: Nashrah, Zannatul
Publicado em: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
Por: Rahman, Qazi Ashrafur
Publicado em: (2018)